• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis.载脂蛋白 E 和 LRP1 在帕金森病发病早期增加。
Am J Pathol. 2011 Nov;179(5):2152-6. doi: 10.1016/j.ajpath.2011.07.021. Epub 2011 Sep 9.
2
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
3
[Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].[帕金森病中的路易小体形成:神经退行性变还是神经保护?]
Rinsho Shinkeigaku. 2008 Nov;48(11):981-3. doi: 10.5692/clinicalneurol.48.981.
4
[The mechanism of Lewy body formation in Parkinson's disease].[帕金森病中路易小体形成的机制]
Nihon Rinsho. 2000 Oct;58(10):2022-7.
5
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.α-突触核蛋白免疫反应性皮质路易小体与帕金森病的认知障碍有关。
Acta Neuropathol. 2000 Sep;100(3):285-90. doi: 10.1007/s004019900168.
6
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.帕金森病脑中的路易体提取物在小鼠和猴子中引发α-突触核蛋白病理和神经退行性变。
Ann Neurol. 2014 Mar;75(3):351-62. doi: 10.1002/ana.24066. Epub 2014 Feb 18.
7
Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.厘清帕金森病中路易小体与黑质神经元丢失之间的关系。
J Parkinsons Dis. 2011;1(3):277-86. doi: 10.3233/JPD-2011-11046.
8
Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.黑质中路易小体和路易神经突内囊泡单胺转运体2呈阳性免疫反应性。
Neurosci Lett. 2006 Apr 3;396(3):187-91. doi: 10.1016/j.neulet.2005.11.068. Epub 2005 Dec 28.
9
TIGAR inclusion pathology is specific for Lewy body diseases.TIGAR 包涵体病理学是路易体病的特征。
Brain Res. 2019 Mar 1;1706:218-223. doi: 10.1016/j.brainres.2018.09.032. Epub 2018 Sep 26.
10
The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.帕金森病中的路易小体:与α-突触核蛋白聚集体形成和降解相关的分子。
Neuropathology. 2007 Oct;27(5):494-506. doi: 10.1111/j.1440-1789.2007.00803.x.

引用本文的文献

1
A Transcriptomic Roadmap of Parkinson's Disease Progression at Single Cell Resolution.单细胞分辨率下帕金森病进展的转录组学路线图
medRxiv. 2025 Jul 30:2025.07.30.25332436. doi: 10.1101/2025.07.30.25332436.
2
ApoE: The Non-Protagonist Actor in Neurological Diseases.载脂蛋白 E:神经疾病中的非主角演员。
Genes (Basel). 2024 Oct 30;15(11):1397. doi: 10.3390/genes15111397.
3
Role of Lipids in the Pathogenesis of Parkinson's Disease.脂质在帕金森病发病机制中的作用。
Int J Mol Sci. 2024 Aug 16;25(16):8935. doi: 10.3390/ijms25168935.
4
Low-density lipoprotein receptor-related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson's disease.在帕金森病动物模型中,低密度脂蛋白受体相关蛋白1介导α-突触核蛋白从纹状体向黑质的传递。
Neural Regen Res. 2026 Apr 1;21(4):1595-1606. doi: 10.4103/NRR.NRR-D-23-01965. Epub 2024 Jul 29.
5
Blood-brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy.血脑屏障改变及其对帕金森病发病机制和治疗的影响。
Transl Neurodegener. 2024 Jul 29;13(1):37. doi: 10.1186/s40035-024-00430-z.
6
Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons.骨桥蛋白驱动 MAPT-N279K 额颞叶痴呆患者神经元的神经炎症和细胞丢失。
Cell Stem Cell. 2024 May 2;31(5):676-693.e10. doi: 10.1016/j.stem.2024.03.013. Epub 2024 Apr 15.
7
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis.α-突触核蛋白的羧基端截断发生较早,并受载脂蛋白 E 基因型影响在 α-突触核蛋白发病机制的转基因小鼠模型中。
Acta Neuropathol Commun. 2023 Jul 23;11(1):119. doi: 10.1186/s40478-023-01623-9.
8
Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit.海马突触功能衰竭是实验性帕金森病伴轻度认知缺陷的早期事件。
Brain. 2023 Dec 1;146(12):4949-4963. doi: 10.1093/brain/awad227.
9
Neuropathology of incidental Lewy body & prodromal Parkinson's disease.偶然Lewy 体与前驱帕金森病的神经病理学。
Mol Neurodegener. 2023 May 12;18(1):32. doi: 10.1186/s13024-023-00622-7.
10
Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases.载脂蛋白E与神经退行性疾病中淀粉样蛋白之间的交叉相互作用。
Comput Struct Biotechnol J. 2023 Jan 20;21:1189-1204. doi: 10.1016/j.csbj.2023.01.022. eCollection 2023.

本文引用的文献

1
Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson's disease brain.颗粒内质网中组织转谷氨酰胺酶的存在是帕金森病大脑中黑色素化神经元的特征。
Brain Pathol. 2011 Mar;21(2):130-9. doi: 10.1111/j.1750-3639.2010.00429.x. Epub 2010 Aug 20.
2
Alpha-synuclein, lipids and Parkinson's disease.α-突触核蛋白、脂质与帕金森病。
Prog Lipid Res. 2010 Oct;49(4):420-8. doi: 10.1016/j.plipres.2010.05.004. Epub 2010 May 23.
3
Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake.受体相关蛋白与淀粉样β肽相互作用,并促进其细胞摄取。
J Biol Chem. 2009 Nov 27;284(48):33352-9. doi: 10.1074/jbc.M109.015032. Epub 2009 Oct 13.
4
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.载脂蛋白E及其受体与阿尔茨海默病:途径、发病机制及治疗
Nat Rev Neurosci. 2009 May;10(5):333-44. doi: 10.1038/nrn2620. Epub 2009 Apr 2.
5
Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.载脂蛋白E基因型作为帕金森病易感性和痴呆的危险因素。
J Neurol. 2009 Mar;256(3):493-8. doi: 10.1007/s00415-009-0119-8. Epub 2009 Mar 18.
6
A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.对路易体疾病中α-突触核蛋白病理学当前分期的批判性评估。
Biochim Biophys Acta. 2009 Jul;1792(7):730-40. doi: 10.1016/j.bbadis.2008.07.006. Epub 2008 Aug 5.
7
A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.一条将α-突触核蛋白与载脂蛋白E及β淀粉样肽联系起来的神经退行性变分子通路。
Nat Neurosci. 2008 Mar;11(3):301-8. doi: 10.1038/nn2058. Epub 2008 Feb 24.
8
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.有证据表明,偶发性路易体病是帕金森病的症状前阶段。
Acta Neuropathol. 2008 Apr;115(4):437-44. doi: 10.1007/s00401-008-0345-7. Epub 2008 Feb 9.
9
Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells.脂蛋白受体相关蛋白-1介导淀粉样β蛋白引起的脑血管细胞死亡。
Am J Pathol. 2007 Dec;171(6):1989-99. doi: 10.2353/ajpath.2007.070050. Epub 2007 Nov 30.
10
Parkinson's disease: premotor clinico-pathological correlations.帕金森病:运动前临床病理相关性
J Neural Transm Suppl. 2006(70):309-19. doi: 10.1007/978-3-211-45295-0_47.

载脂蛋白 E 和 LRP1 在帕金森病发病早期增加。

Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis.

机构信息

Department of Anatomy and Neurosciences, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Am J Pathol. 2011 Nov;179(5):2152-6. doi: 10.1016/j.ajpath.2011.07.021. Epub 2011 Sep 9.

DOI:10.1016/j.ajpath.2011.07.021
PMID:21907175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3204035/
Abstract

Parkinson's disease (PD) is characterized by α-synuclein-containing Lewy bodies (LBs) and loss of melanized neurons in the substantia nigra (SN). Recently, a link between apolipoprotein E (ApoE) expression, α-synuclein aggregation, and neurodegeneration was suggested. Here, we report on ApoE expression appearing in melanized neurons of the SN and in LBs in both PD and incidental LB disease cases. Interestingly, increased expression of the low-density lipoprotein receptor-related protein 1 (the receptor for ApoE) was also observed in incidental LB disease and PD. Our data suggest that alterations in lipoprotein homeostasis/signaling in melanized neurons of the SN are an early event during PD pathogenesis.

摘要

帕金森病(PD)的特征是含有α-突触核蛋白的路易体(LB)和黑质(SN)中黑色素神经元的丧失。最近,有人提出载脂蛋白 E(ApoE)表达、α-突触核蛋白聚集和神经退行性变之间存在联系。在这里,我们报告了 ApoE 表达出现在 SN 中的黑色素神经元和 PD 和偶发性 LB 疾病病例中的 LB 中。有趣的是,在偶发性 LB 疾病和 PD 中也观察到低密度脂蛋白受体相关蛋白 1(ApoE 的受体)的表达增加。我们的数据表明,SN 中黑色素神经元的脂蛋白稳态/信号转导改变是 PD 发病机制中的早期事件。